China’s National Medical Products Administration (NMPA) has approved Bracco Imaging’s ultrasound contrast agent, sulphur hexafluoride (SF6) microbubbles, for use in a contrast-enhanced ultrasound (CEUS) procedure that aids in the diagnosis of female infertility.

The hysterosalpingo-contrast-sonography (HyCoSy) procedure is instrumental in detecting potential reasons for infertility associated with fallopian tube blockages or uterine abnormalities.

Utilising SF6 microbubbles, HyCoSy is said to offer a non-invasive and radiation-free diagnostic alternative to traditional methods such as tubal patency’s laparoscopic assessment and X-ray hysterosalpingography.